Labcorp has acquired MLM Medical Labs for an undisclosed amount, a move that expands the contract research organization’s footprint in Europe and the United States. The transaction brings the specialty and central laboratory under Labcorp’s drug development division, which provides clinical trial testing and related services to pharmaceutical and biotechnology clients.
MLM Medical Labs operates as a central laboratory offering standard and customizable analytical and logistics services across multiple therapeutic areas. Its capabilities span nonclinical and preclinical research through phase IV clinical trials, with a focus on in vitro and ex vivo analyses that measure therapeutic effects across more than 900 parameters. The company serves clients ranging from emerging biotech firms to large global pharmaceutical companies, supported by a reputation for scientific expertise and quality data delivery.
For Labcorp, the acquisition strengthens its capacity to support complex and late-stage clinical programs, particularly in specialty testing areas where MLM Medical Labs has established depth. The deal also broadens Labcorp’s geographic reach in Europe, complementing its existing U.S.-based laboratory network. By integrating MLM Medical Labs’ analytical models and logistics infrastructure, Labcorp aims to offer sponsors a more seamless pathway from early research through post-marketing studies.
The combined entity is expected to provide a wider menu of testing services and faster turnaround for multinational trials, as Labcorp leverages MLM Medical Labs’ specialized assays alongside its own scale. Clients may benefit from a single provider capable of handling both routine and highly customized laboratory needs across regions. The integration process will likely focus on harmonizing quality systems and data standards to ensure consistent results for global studies.
With this purchase, Labcorp adds a specialized asset that could help it compete for more complex trial contracts, while MLM Medical Labs gains access to broader commercial resources and an established client network. The full impact on pricing and service offerings will become clearer as the companies align their operations over the coming quarters.